Scholar Rock (NASDAQ: SRRK; the "Company"), a late-stage biopharmaceutical company focused on advancing innovative treatments ...

Composer Ari Kinarthy, who has a rare genetic condition called Spinal Muscular Atrophy, is the subject of Ari’s Theme, ...

Natco Pharma stock corrected sharply due to weak Q3 results, but future opportunities like semaglutide offer hope.

With Class X Board examinations having begun, The Hindu Downtown takes a close look at the daily schedule of three young ...

Finding the right shoes can be tough, but for people who wear braces, the challenge is even bigger. One Murfreesboro man is ...

Lakeside Holding Limited ("Lakeside" or the "Company") , a U.S.-based cross-border supply chain solution provider with a unique focus on the Asia-Pacific market operating through two specialized ...

Biogen’s disappointing Leqembi performance and weak pipeline hurt future growth. Learn why BIIB stock is rated "sell" due to ...

Equities research analysts at Cantor Fitzgerald decreased their FY2025 earnings estimates for Biogen in a research note ...

Biogen (NASDAQ:BIIB – Get Free Report)‘s stock had its “hold” rating reiterated by equities research analysts at Needham & ...

Numinus Wellness Inc. ("Numinus" or the "Company") , a mental healthcare company advancing traditional and innovative behavioral health treatments including safe, evidence-based psychedelic-assisted ...

Basel: Roche, announced that the U.S. Food and Drug Administration (FDA) has approved a New Drug Application (NDA) for an ...

The University of Auckland trial - involving more than one thousand children across Australasia will determine if the medicine can be beneficial here. Paediatrician and researcher Doctor Cameron Grant ...